Japan's Daiichi Strikes Cancer Therapy Deal With Astra Zeneca Worth Up To $6.9B
Daiichi Sankyo Company, Limited has entered into a global development and commercialization agreement with AstraZeneca for Daiichi Sankyo's lead antibody drug conjugate (ADC), [fam-] trastuzumab deruxtecan (DS-8201), now in pivotal development for multiple HER2 expressing cancers including breast and gastric cancer, and additional development in non-small cell lung and colorectal cancer.
Separately, AstraZeneca said it would pay for the upfront payment and near-term milestones to Daiichi Sankyo from the proceeds of a new $3.5 billion equity placement, more than half of which AstraZeneca plans to use toward the transaction and ongoing collaboration.
Chief executive Pascal Soriot, who has made investment in cancer treatments a focus of his tenure, said: "We believe that trastuzumab deruxtecan could become a transformative new medicine for the treatment of HER2-positive breast and gastric cancers".
The drug, called Trastuzumab Deruxtecan, allows chemotherapy products to target specific cancer tumours.
'The transaction is expected to be neutral to core earnings in 2019, with growing Core EPS accretion from 2020 and making a significant contribution in 2023, ' AstraZeneca said.
In contrast to traditional chemotherapy treatments, trastuzumab deruxtecan has been created to target and delivery chemotherapy inside cancer cells, helping to reduce side-effets from the treatment. Daiichi Sankyo has said that means its drug can carry a greater cytotoxic payload.
The partnership would add to shareholder value over the medium to long term, Daiichi said.
Priyanka, Jonas heading for a divorce?
On Sunday, the global icon took to her Instagram page and shared a photo in which she can be seen striking a pose with the Jonas brothers.
Goldman Sachs International and Morgan Stanley & Co are acting as joint global coordinators and joint bookrunners on behalf of AstraZeneca on the placing. For the Japanese firm, the tie-up is its biggest licensing deal ever, said Stuart Mackey, Daiichi's head of global business development.
The companies will jointly develop and commercialize trastuzumab deruxtecan worldwide, except in Japan where Daiichi Sankyo will maintain exclusive rights.
The global development and commercialisation agreement covers the potential cancer treatment trastuzumab deruxtecan.
The treatment received a breakthrough therapy designation from the U.S. Food and Drug Administration in 2017, a status which is given in instances where there is no current medicine for the condition the drug is aimed at.
An approval could occur soon: the companies intend to make the first regulatory filing of the drug in the second half of the year, for advanced or refractory breast cancer. In the US, the largest pharmaceutical market, Daiichi Sankyo will record sales and then split profits.
This is not the first time the two companies have been linked.
Despite a couple of knockbacks in trials seeking to expand its uses into other indications such as gastric cancer, Kadcyla has become an important part of Roche's anti-HER2 portfolio with sales approaching $1bn a year ago. Daiichi denied the reports.
Recommended News
-
31 March 2019Rolling Stones delay tour as Jagger seeks medical treatment
In March 2014 the group postponed a tour of Australia and New Zealand after the suicide of Jagger's life partner, L'Wren Scott. Jagger said in the statement posted on social media on Saturday morning, "I really hate letting you down like this".
31 March 2019Sega's 'Sega Genesis Mini' Console Launches with 40 Games on September 19
Both of the systems in these regions come packaged with the original 3-button controllers (see below). Retro gaming is not only alive and well, it is downright thriving, at least for Nintendo .
31 March 2019Slovakia could elect its 1st female head of state
Jan Kuciak was looking into links between politicians and organised crime when he was shot alongside his fiancée in February 2018. Caputova cited Jan Kuciak's death as one of the reasons she chose to run for president, which is a largely ceremonial role. -
31 March 2019Google gets into gaming with streaming service launch
The Labs have around 6000 employees who dedicate their working hours exclusively to improving Walmart's digital branch. The service is bolstered by Google's own first-party game studio and is expected to launch later this year.
31 March 2019Newsroom Pauline Hanson Defiant Over Guns Scandal a day ago
I feel that this has been dubbed out and it has been cut and pasted so many times". "A lot of questions there", Ms Hanson added. She also said that Mr Ashby and Mr Dickson, two party leaders implicated in the video, would retain their positions.
31 March 2019Whoops, Google might have leaked the new Nest Hub Max smart speaker
With these various displays, users can call upon Google Assistant to control their smart home products. Alongside the new Pixel 3 and Chromecast, Google also recently announced the Google Home Hub. -
31 March 2019Montreal school board to ignore latest Quebec religious symbols law
In October 2017, Quebec's previous Liberal government passed a bill banning face coverings for those receiving public services. However there wouldn't be a "strip search to check if the person is wearing a religious sign", he said.
31 March 2019Kristaps Porzingis Under Investigation For Alleged Rape of Woman by The NYPD
The woman told police on Thursday about the alleged attack, according to the Post report, which cited law enforcement sources. The woman, who lived in the same building as Porzingis, alleged he raped her on February 7, 2018, in his Manhattan penthouse.
31 March 2019Missing 21-year-old USC student from New Jersey found dead
Friends told police they were concerned as Josephson didn't show up at her downtown home or failed to answer repeated phone calls. Officials said a suspect identified as Nathaniel David Rowland has been arrested in connection with Josephson's death. -
31 March 2019Nielsen asks Congress for new authorities to deport and detain migrants
And then Dobbs said he's calling on Trump to "fire these incompetents in the leadership of the Department of Homeland Security and Customs Border Protection".
31 March 2019Hammers open to selling Rice
Pellegrini confirmed playmaker Samir Nasri is a doubt with a calf problem, while striker Andy Carroll is continuing to undergo tests on his injured ankle.
31 March 2019United Nations urges Israel, Hamas to avoid violence on Gaza anniversary
Hamas leaders said on Saturday progress had been made in the Egyptian talks but that they still had a list of demands from Israel. The army also said it caught two young Palestinian children who had tried to cross the border with a knife.
.jpg)
